Ingalls & Snyder LLC has filed its 13F form on May 12, 2025 for Q1 2025 where it was disclosed a total value porftolio of $3.04 Billion distributed in 456 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Corcept Therapeutics Inc with a value of $884M, Berkshire Hathaway Inc Class B with a value of $96.6M, Exxon Mobil Corp with a value of $94.5M, Apple Inc. with a value of $90.2M, and Williams Companies, Inc. with a value of $84.6M.

Examining the 13F form we can see an increase of $491M in the current position value, from $2.55B to 3.04B.

Ingalls & Snyder LLC is based out at New York, NY

Below you can find more details about Ingalls & Snyder LLC portfolio as well as his latest detailed transactions.

Portfolio value $3.04 Billion
Healthcare: $1.12 Billion
Energy: $358 Million
Financial Services: $334 Million
Technology: $306 Million
Industrials: $197 Million
Communication Services: $163 Million
Consumer Cyclical: $155 Million
Consumer Defensive: $119 Million
Other: $234 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 456
  • Current Value $3.04 Billion
  • Prior Value $2.55 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 12, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 25 stocks
  • Additional Purchases 113 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 199 stocks
Track This Portfolio

Track Ingalls & Snyder LLC Portfolio

Follow Ingalls & Snyder LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.